Eloxx Stock Moves Higher On Fast Track Tag For Cystic Fibrosis Candidate
Why AzurRx Stock Is Trading Higher After MS1819 Combo Therapy Data?
Eloxx Pharma Sees Data Readout From First Four Arms Of Cystic Fibrosis Study By End Of 2021
Arrowhead Stock Drops After RNAi Therapeutic Shows Lung Inflammation In Animal Models
Cystic Fibrosis Recent News
Vertex Pharma's Trikafta Triplet Therapy Wins FDA Approval For Expanded Use In Children 6-11 Years With Cystic Fibrosis
Concert Pharma Sells VX-561-Related Milestones To Vertex For $32M
AzurRx BioPharma Stock Gains On Positive MS1819-PERT Combo Data In Pancreatic Insufficiency
AzurRx's Stock Falls After MS1819 For Pancreatic Insufficiency Flunks Mid-Stage Study
Translate Bio Shares Drop After Its mRNA-Based Cystic Fibrosis Candidate Did Not Improve Lung Function
Eloxx Pharma Says ELX-02 Data Showed Increases In Key Metric
Proteostasis Therapeutics Rallies After Cystic Fibrosis Drug Is Granted Orphan Designation
Proteostasis Therapeutics Rallies On Genentech Licensing Agreement
Proteostasis Therapeutics Shares Surge On Positive Preliminary Cystic Fibrosis Trial Results
3 Reasons To Like Vertex Pharma Shares
More Than 30% Upside Seen For Vertex Stock On The Heels Of Phase 2 Data
Corbus Pharma's Positive Phase 2 Study: Safety First
Here's Why Shares Of Vertex Pharmaceuticals Tumbled
Goldman Comments On Vertex Pharmaceuticals Following FDA Approval
Cystic Fibrosis Market is Forecast to Show Positive Growth until 2017